2011 ACCF/AHA/HRS Focused Update on the Management of Patients With Atrial Fibrillation (Update on Dabigatran) A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

L. Samuel Wann, Anne B. Curtis, Kenneth A. Ellenbogen, N. A. Mark, III Estes, Michael D. Ezekowitz, Warren M. Jackman, Craig T. January, James E. Lowe, Richard L. Page, David J. Slotwiner, William G. Stevenson, Cynthia M. Tracy, Valentin Fuster, Lars E. Ryden, David S. Cannom, Harry J. Crijns, Jonathan L. Halperin, G. Neal Kay, Jean-Yves Le Heuzey, S. Bertil OlssonEric N. Prystowsky, Juan Luis Tamargo, Alice K. Jacobs, Jeffrey L. Anderson, Nancy M. Albert, Mark A. Creager, Steven M. Ettinger, Robert A. Guyton, Judith S. Hochman, Frederick G. Kushner, Erik Magnus Ohman, Clyde W. Yancy

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)E1-E8
JournalHeart Rhythm
Volume8
Issue number3
DOIs
Publication statusPublished - Mar 2011

Keywords

  • AHA Scientific Statements
  • Focused update
  • Atrial fibrillation
  • Dabigatran
  • Antithrombotic agents

Cite this